
The Drug Patent Two-Step
Drug companies are willing to try everything to keep their valuable patents alive.
Drug companies are willing to try everything to keep their valuable patents alive.
Here are three big reasons why, according to IP columnist Tom Kulik.
Help us benchmark your organization with this survey and have a chance to win a $250 gift card.
Which law firms were at the top of our patent category through Q3 2017?
If this tactic is allowed, it will be a big win for Big Pharma -- and a big loss for patients and consumers.
When the underlying technology is so potentially valuable, companies will go to war on multiple fronts.
Here's what you need to know in 2017, in an easily consumable way.
Drowning in marketing to-dos? Learn how firms use AI—the right way—to build lead magnets, rank in AI search, turn referrals into revenue, and craft data-driven business plans.